|View printer-friendly version|
|September 28, 2000 3:31 p.m.|
|Teva Announces Final Approval of Nifedipine XL 60 mg and will Launched Imminently|
Jerusalem, Israel, September 28, 2000 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the FDA awarded final U.S. approval for Nifedipine XL 60mg. This approval was issued to Biovail Corporation. The product is included in the exclusive US marketing agreement between Teva and Biovail relating to Biovail's line of generic sustained release products.